Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Clinical trial NCT00695682 · UNKNOWN

Trial details

NCT number: NCT00695682
Sponsor: Retina Research Foundation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Retinopathy Macular Degeneration

Start date: 2008-06-01
Primary completion: 2008-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.